|
May 15
|
Molecular Templates, Inc. Reports First Quarter 2024 Financial Results and Corporate Update
|
|
Apr 9
|
Molecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer Pa...
|
|
Mar 29
|
Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update
|
|
Mar 28
|
Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement
|
|
Mar 4
|
Molecular Templates, Inc. Provides Interim Update
|
|
Feb 8
|
Molecular Templates to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference
|
|
Nov 13
|
Molecular Templates, Inc. Reports Third Quarter 2023 Financial Results and Business Update
|
|
Jul 13
|
Molecular Templates Announces Up to $40 Million Private Placement Offering
|
|
Apr 7
|
Molecular Templates Announces Partial Clinical Hold for Phase 1 Study of MT-0169
|